Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Current Cancer Drug Targets|January 11, 2012
Genetic variants in genes involved in mechanisms of chemoresistance to anticancer drugsJ J G Marin, O Briz, M J Monte, et al.Current Molecular Medicine|June 15, 2010
Strategies for overcoming chemotherapy resistance in enterohepatic tumoursJ J G Marin, B Castaño, A G Blazquez, et al.Journal of Lipid Research|September 19, 1998
Transport and biotransformation of the new cytostatic complex cis-diammineplatinum(II)-chlorocholylglycinate (Bamet-R2) by the rat liverR I Macias, M J Monte, M Y El-Mir, et al.Hepatology (Baltimore, Md.)|May 1, 1996
Reversible impairment of neonatal hepatobiliary function by maternal cholestasisM J Monte, A I Morales, M Arevalo, et al.International Journal of Experimental Pathology|April 1, 1992
Further evaluation of the interrelationship between the hepatocellular transport of bile acids and endocytosed proteinsM C Herrera, M Y el-Mir, M J Monte, et al.Digestive Diseases and Sciences|November 28, 2002
Chronic renal failure-induced changes in serum and urine bile acid profilesF Jimenez, M J Monte, M Y El-Mir, et al.Life Sciences|June 13, 2006
Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liverR I R Macias, S Jimenez, M A Serrano, et al.Life Sciences|March 29, 2000
Bile acid secretion during rat liver carcinogenesisM J Monte, F Palomero, G R Sainz, et al.International Journal of Cancer|October 10, 1998
DNA interaction and cytostatic activity of the new liver organotropic complex of cisplatin with glycocholic acid: Bamet-R2J J Marin, R I Macias, J J Criado, et al.Clinical Science (London, England : 1979)|February 9, 2002
Changes in the pattern of bile acids in the nuclei of rat liver cells during hepatocarcinogenesisM E Mendoza, M J Monte, M Y El-Mir, et al.Pageof 5